The DOI matches its Crossref record.
Human Alternative Complement Pathway: Membrane-Associated Sialic Acid Regulates the Competition between B and β1H for Cell-Bound C3b
Abstract
The relative affinity of B and β1H for particle-bound C3b is influenced by the relative abundance of cell surface sialic acid moieties and determines whether or not the particle has the capacity to activate the human alternative complement pathway. The effect of membrane sialic acid on the binding of B and β1H to particle bound C3b was determined with radiolabeled proteins and a technique for separating bound from free ligand by centrifugation of the particles through an oil/aqueous interphase. The affinity constants at equilibrium and the effective number of C3b binding sites for B and β1H on the particles were determined by Scatchard analysis of the binding data. The sheep erythrocyte (Es) served as a nonactivating particle, whereas the activating particles included Es from which 80% of the membrane sialic acid residues had been removed by sialidase or 80 to 85% had been converted to heptulosonic acid by NaIO4 and NaBH4 treatment and zymosan particles that lack sialic acid. The affinity constants at equilibrium for C3b on EsC3b were 1 × 107 M-1 for β1H and 2.1 × 106 M-1 for B, in the presence of 5 mM Mg++, indicating an approximately 5-fold greater affinity of β1H for the binding sites that were present in approximately equal numbers for the two ligands as determined by Scatchard analysis. The affinity of B at equilibrium for C3b bound to sialic acid-deficient sheep erythrocytes and to zymosan was the same as that for C3b on Es, and the calculated number of effective binding sites for B agreed with the number of sites estimated by the prior uptake of radiolabeled C3b. In contrast, the number of C3b binding sites with an affinity for β1H of approximately 107 M-1 on sialic acid-deficient EsC3b or ZyC3b was only ⅕ to ⅙ the number interacting with B. The presence of additional binding sites for β1H with an affinity so low that they were not revealed by the Scatchard analysis because of the dominant effect of the high affinity sites was determined in competitive binding studies between B and β1H for C3b on sialic acid-deficient surfaces. The affinity constant of β1H for these sialic acid independent C3b sites is approximately 7 × 105 M-1, a Kβ1H at least 10-fold less than that of the sialic acid-dependent high affinity C3b sites. The relative inefficiency of β1H in competing with 125I-B for uptake by C3b on the sialic acid-deficient erythrocytes correlated with the decreased capacity of β1H to decay-dissociate C3b,Bb from such particles. Thus a deficiency of sialic acid diminishes the number of high affinity C3b sites for β1H and creates an activating particle on which binding of B by C3b is favored relative to β1H and decay-dissociation of C3b,Bb by β1H is impaired.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Complement System Part I – Molecular Mechanisms of Activation and Regulation
Merle, N. S., Church, S. E., Fremeaux-Bacchi, V., & Roumenina, L. T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00262 · Cited by 1,620
Chemical Diversity in the Sialic Acids and Related α-Keto Acids: An Evolutionary Perspective
Angata, T., & Varki, A. (2002) · Chemical Reviews · doi:10.1021/cr000407m · Cited by 1,237
Overview of complement activation and regulation
Noris, M., & Remuzzi, G. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.08.001 · Cited by 864
Schenkman, S., Jiang, M.-S., Hart, G. W., & Nussenzweig, V. (1991) · Cell · doi:10.1016/0092-8674(91)90008-m · Cited by 420
Molecular Biology and Chemistry of the Alternative Pathway of Complement
Müller-Eberhard, H. J., & Schreiber, R. D. (1980) · Advances in Immunology · doi:10.1016/s0065-2776(08)60042-5 · Cited by 408
Infections of People with Complement Deficiencies and Patients Who Have Undergone Splenectomy
Ram, S., Lewis, L. A., & Rice, P. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00048-09 · Cited by 405
Ram, S., Sharma, A. K., Simpson, S. D., Gulati, S., McQuillen, D. P., Pangburn, M. K., & Rice, P. A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.5.743 · Cited by 398
Stealth Properties to Improve Therapeutic Efficacy of Drug Nanocarriers
Salmaso, S., & Caliceti, P. (2013) · Journal of Drug Delivery · doi:10.1155/2013/374252 · Cited by 340
O'Keefe, T. L., Williams, G. T., Batista, F. D., & Neuberger, M. S. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.8.1307 · Cited by 320
Exploration of the Sialic Acid World
(2018) · Advances in Carbohydrate Chemistry and Biochemistry · doi:10.1016/bs.accb.2018.09.001 · Cited by 320
Membrane Complement Receptors Specific for Bound Fragments of C3
Ross, G. D., & Medof, M. E. (1985) · Advances in Immunology · doi:10.1016/s0065-2776(08)60341-7 · Cited by 308
Caprioli, J., Castelletti, F., Bucchioni, S., Bettinaglio, P., Bresin, E., Pianetti, G., Gamba, S., Brioschi, S., Daina, E., Remuzzi, G., et al. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg363 · Cited by 306
The alternative pathway of complement
Pangburn, M. K., & Müller-Eberhard, H. J. (1984) · Springer Seminars in Immunopathology · doi:10.1007/bf01893019 · Cited by 291
De Córdoba, S. R., & De Jorge, E. G. (2007) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2007.03552.x · Cited by 287
Complement alternative pathway acts as a positive feedback amplification of neutrophil activation
Camous, L., Roumenina, L., Bigot, S., Brachemi, S., Frémeaux-Bacchi, V., Lesavre, P., & Halbwachs-Mecarelli, L. (2011) · Blood · doi:10.1182/blood-2010-05-283564 · Cited by 244
Structural basis for complement factor H linked age-related macular degeneration
Prosser, B. E., Johnson, S., Roversi, P., Herbert, A. P., Blaum, B. S., Tyrrell, J., Jowitt, T. A., Clark, S. J., Tarelli, E., Uhrín, D., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071069 · Cited by 184
Clark, S. J., Higman, V. A., Mulloy, B., Perkins, S. J., Lea, S. M., Sim, R. B., & Day, A. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605083200 · Cited by 185
Giannakis, E., Jokiranta, T. S., Male, D. A., Ranganathan, S., Ormsby, R. J., Fischetti, V. A., Mold, C., & Gordon, D. L. (2003) · European Journal of Immunology · doi:10.1002/eji.200323541 · Cited by 166
Self‐nonself discrimination by the complement system
Meri, S. (2016) · FEBS Letters · doi:10.1002/1873-3468.12284 · Cited by 87
Hijacking Factor H for Complement Immune Evasion
Moore, S. R., Menon, S. S., Cortes, C., & Ferreira, V. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.602277 · Cited by 83
Self versus nonself discrimination by the soluble complement regulators factor H and FHL-1
Dopler, A., Guntau, L., Harder, M. J., Palmer, A., Höchsmann, B., Schrezenmeier, H., Simmet, T., Huber-Lang, M., & Schmidt, C. Q. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801545 · Cited by 35
Metadata
- Authors
- Kazatchkine, M. D., Fearon, D. T., & Austen, K. F.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1979-01-01
- Volume
- 122
- Issue
- 1
- Pages
- 75-81
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W4313342417
- Cited by
- 290
- References
- 0
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.